Skip to main content
Log in

Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymeraseα in human tumour lines: implications for in vitro chemoresistance

  • Original Papers
  • Experimental Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

To compare the time course of in vitro expression of various proliferation-associated markers including Ki-67 antigen, transferrin receptors (TfR), and DNA polymerase α, six human tumour cell lines of different histological origin were studied under defined conditions. Proliferation markers were demonstrated by peroxidase/anti-peroxidase staining using specific monoclonal antibodies, and their expression was compared to results obtained from [3H]-thymidine incorporation assays and cell counting. Expression of all proliferation markers began to increase during the lag phase, and occurred earlier than elevations of [3H]dT incorporation and cell numbers were recorded. Maximum expression was observed before cell growth reached plateau phase. The time courses of expression of DNA polymerase and Ki-67 were almost identical. The closest correlation of [3H]dT incorporation with time course of expression of proliferation-associated markers was observed, when intranuclear staining of DNA polymerase was analysed. TfR were expressed earlier than the polymerase and Ki-67. Since TfR were also found at remarkable levels in resting cells, they seem less proliferation-specific than Ki-67 and DNA polymerase. While in rapidly growing cell lines more than 95% of the cells expressed Ki-67, TfR, and more than 75% DNA polymerase in cell nuclei, a malignant melanoma and a pleural mesothelioma line displayed fewer than 35% of cells stained for DNA polymerase in cell nuclei during log phase. Determination of growth fractions by monoclonal antibodies may thus contribute to the prediction of chemoresistance by identifying quiescent cells that are not sensitive to S-phasespecific drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

TfR:

transferrin receptors

References

  • Alama A, Conte PF, Di Marco E, Favoni RE, Nicolin A (1986) Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent α-DNA polymerase. Oncology 43:385–389

    PubMed  Google Scholar 

  • Alama A, Nicolin A, Conte FF, Drewinko B (1987) Evaluation of growth fractions with monoclonal antibodies to human α-DNA polymerase. Cancer Res 47:1982–1986

    Google Scholar 

  • Baisch H, Gerdes J (1987) Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation-associated antibody Ki-67 and propidium iodide: analysis by flow cytometry. Cell Tissue Kinet 20:387–391

    PubMed  Google Scholar 

  • Barlogie B, Johnson DA, Smallwood L, Rober MN, Maddox AM, Latreille J, Swartzendruber DE, Drewinko B (1981) Prognostic implications of ploidity and proliferative activity in human solid tumors. Cancer Genet Cytogenet 6:17–28

    Google Scholar 

  • Barnard NJ, Hall PA, Lemoine NR, Kadar N (1987) Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol 152:287–295

    PubMed  Google Scholar 

  • Bensch KG, Tanaka S, Hu SZ, Wang TSF, Korn D (1982) Intracellular localization of human DNA polymerase α with monoclonal antibodies. J Biol Chem 257:8391–8396

    PubMed  Google Scholar 

  • Berger DP, Henss H, Winterhalter BR, Fiebig HH (1990) The clonogenic assay with human tumor xenografts. Evaluation, predictive value and application for drug screening. Ann Oncol 1:333–341

    PubMed  Google Scholar 

  • Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 10:611–617

    PubMed  Google Scholar 

  • Düe W, Dieckmann KP, Loy V (1988) Immunohistological determination of proliferative activity in seminomas. J Clin Pathol 41:304–307

    PubMed  Google Scholar 

  • Faulk WP, Hsi BL, Stevens PJ (1980) Transferrin and transferrin receptors in carcinoma of the breast. Lancet 2:390–392

    PubMed  Google Scholar 

  • Fiebig HH, Widmer KH, Fiedler L, Wittekind C, Löhr GW (1984) Development and characterization of 51 human tumor models for large bowel, stomach and esophageal cancer. Dig Surg 1:225–235

    Google Scholar 

  • Fiebig HH, Schmid JR, Bieser W, Henss H, Löhr GW (1987) Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development. Eur J Cancer Clin Oncol 23:937–948

    PubMed  Google Scholar 

  • Gerdes J (1985) An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during sugery. Int J Cancer 35:169–171

    PubMed  Google Scholar 

  • Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710–1715

    PubMed  Google Scholar 

  • Hedley DH, Rugg CA, Gelber DA (1985) Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 47:4729–4735

    Google Scholar 

  • Lellé RJ, Heidenreich W, Stauch G, Gerdes J (1987) The correlation of growth fractions with histolgic grading and lymph node status in human mammary carcinoma. Cancer 59:83–88

    PubMed  Google Scholar 

  • Licht T, Fiebig HH, Bross KJ, Herrmann F, Berger DP, Shoemaker R, Mertelsmann R (1991) Induction of multiple-drug resistance during antineoplastic chemotherapy in vitro. Int J Cancer 49:630–637

    PubMed  Google Scholar 

  • Mushika M, Tadashi M, Suzuoki Y, Hayashi K, Masaki S, Kaneda T (1988) Detection of proliferative cells in dysplasia, carcinoma in situ, and invasive carcinoma of the uterine cervix by monoclonal antibody against DNA polymerase α Cancer 61:1182–1186

    PubMed  Google Scholar 

  • Nakamura H, Morita T, Masaki S, Yoshida S (1984) Intracellular localization of DNA polymerase α in human cells visualized with monoclonal antibody. Exp Cell Res 151:123–133

    PubMed  Google Scholar 

  • Scott CS, Ramsden W, Limbert HJ, Master PS, Roberts BE (1988) Membrane transferrin receptor (TfR) and nuclear proliferation-associated Ki-67 expression in hemopoetic malignancies. Leukemia 2:438–42

    PubMed  Google Scholar 

  • Shepherd NA, Richman PI, England J (1988) Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J Pathol 155:213–219

    PubMed  Google Scholar 

  • Trowbridge IS, Shackelford DA (1986) Structure and function of transferrin receptors and their relationship to cell growth. Biochem Soc Symp 51:117–129

    PubMed  Google Scholar 

  • Weiss LM, Strickler JG, Medeiros LJ, Gerdes J, Stein H, Warnke RA (1987) Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67. Hum Pathol 18:1155–1159

    PubMed  Google Scholar 

  • Yamaguchi A, Takegawa S, Ishida T, Nishimura G, Kato M, Kanno M, Kosaka T, Yonemura Y, Miyazaki I (1990) Detection of the growth fraction in colorectal tumours by a monoclonal antibody against DNA polymerase α. Br J Cancer 61:390–393

    PubMed  Google Scholar 

  • Young SD, Hill RP (1990) Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Nat Cancer Inst 82:371–380

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Licht, T., Bross, K.J., Fiebig, HH. et al. Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymeraseα in human tumour lines: implications for in vitro chemoresistance. J Cancer Res Clin Oncol 118, 116–122 (1992). https://doi.org/10.1007/BF01187499

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01187499

Key words

Navigation